Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-090657

Options or other derivatives

  • EVP, Adaptimmune LLC acquired 704,961 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Binder-Scholl Gwendolyn Knowlton EVP, Adaptimmune LLC 2016-01-18 Grant or award · Option to purchase Ordinary Shares +704,961 704,961 D
Loading xslF345X03/a4.xml…